What Is Critical Limb-Threatening Ischemia (CLTI) and Why Is It Dangerous
You have heard of peripheral artery disease (PAD), where plaque narrows the arteries in your legs and causes leg pain when walking. But there is a more severe, far more dangerous stage of this disease that too many patients discover only when it is nearly too late. Critical Limb-Threatening Ischemia (CLTI) is the most advanced form of PAD. It is a condition where blood flow has become so critically low that the foot is at immediate risk of being lost.
In 2019, the Global Vascular Guidelines officially replaced the older term “critical limb ischemia” (CLI) with CLTI to better reflect that this is always a chronic condition that develops over a period of more than two weeks. Unlike intermittent claudication, where pain comes and goes with walking, CLTI causes pain even when you are resting. Your foot may hurt at night when you lie flat, forcing you to dangle your leg over the side of the bed for relief. Or you may notice a wound on your foot or toe that simply will not heal, no matter what you try.
Without timely treatment, CLTI leads to tissue death (gangrene) and amputation. The statistics are sobering. By one year, up to 40% of CLTI patients will need a lower limb amputation in the absence of revascularization. Even with modern treatment, the one-year mortality rate for patients with CLTI is approximately 20%, and five-year mortality reaches 70%. More than half of those deaths are due to ischemic heart disease. CLTI is not just a leg problem; it is a marker of systemic atherosclerosis that threatens both your limb and your life.
What Are the Warning Signs of Critical Limb-Threatening Ischemia
CLTI does not appear overnight. It is the end stage of years of progressive PAD. Recognizing the warning signs early can mean the difference between a simple endovascular procedure and a major amputation.
Here are the hallmark symptoms that define CLTI:
- Ischemic rest pain: You experience pain in your foot or toes when you are lying flat in bed. The pain is often described as a deep ache or burning sensation. It improves when you sit up or hang your foot over the edge of the bed because gravity helps blood flow into the foot. If you find yourself sleeping in a chair or waking up multiple times each night to walk around and relieve foot pain, this is a major red flag.
- Non-healing wounds or ulcers: Any break in the skin on your foot or leg that has not shown significant improvement after two to four weeks of appropriate wound care should raise concern. In CLTI, these wounds are often located on the toes, heels, or other pressure points. The wound base may appear pale, yellow, or black rather than the healthy red of granulation tissue.
- Gangrene (tissue death): This is the most advanced warning sign. Gangrene appears as black, dry, shriveled tissue on the toes or foot. Once gangrene develops, the affected tissue is dead and cannot be saved. The goal shifts to preventing the gangrene from spreading and saving as much of the foot as possible.
- Cold, pale, or bluish foot: Compare your symptomatic foot to the other foot. If one foot is consistently cooler to the touch, or if the skin color is pale, dusky, or blue, that indicates severely reduced arterial inflow.
- Absent pulses: Your doctor may not be able to feel pulses in the top of your foot (dorsalis pedis) or behind your ankle (posterior tibial).
The non-healing leg or foot wound is often the presentation that finally drives patients to seek help. By then, the window for elective, straightforward revascularization may have narrowed. That is why any patient with PAD risk factors (smoking, diabetes, high blood pressure, high cholesterol, or a family history of vascular disease) should never ignore a foot wound that lingers.
How Do Doctors Diagnose CLTI and Assess Limb Threat
If you present with rest pain, a non-healing wound, or gangrene, your vascular surgeon will perform a focused physical exam and order non-invasive vascular tests. The cornerstone of diagnosis is the ankle-brachial index (ABI), which compares the blood pressure in your ankle to the pressure in your arm. In CLTI, the ABI is typically below 0.5. However, in patients with diabetes or chronic kidney disease, leg arteries may be calcified and non-compressible, producing a falsely normal or even elevated ABI. In these cases, toe-brachial index (TBI) is more reliable because toe arteries rarely calcify. A TBI below 0.4 confirms severe ischemia.
The WIfI Classification System
Diagnosis alone is not enough. To determine the optimal treatment strategy, your surgeon will use the WIfI (Wound, Ischemia, foot Infection) classification system. Developed by the Society for Vascular Surgery, WIfI grades each component on a scale of 0 to 3 (none, mild, moderate, severe) and combines them into a clinical stage from 1 (very low risk of amputation) to 4 (high risk).
| WIfI Component | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
| Wound | No ulcer | Small, shallow ulcer | Deeper ulcer with exposed tendon or bone | Extensive ulcer or gangrene |
| Ischemia | ABI ≥0.8, TBI ≥0.6 | ABI 0.6–0.79, TBI 0.4–0.59 | ABI 0.4–0.59, TBI 0.2–0.39 | ABI <0.4, TBI <0.2 |
| Foot Infection | No infection | Mild, superficial infection | Moderate infection involving deeper tissues | Severe infection with systemic signs |
The WIfI system is not just a research tool; it directly guides treatment decisions. For example, patients with WIfI ischemia grade 2 or 3 and stage 4 (high risk) should be offered revascularization. The classification also provides a common language for all members of the limb salvage team, including vascular surgeons, podiatrists, infectious disease specialists, and wound care experts.
Imaging for Revascularization Planning
Beyond hemodynamic assessment, imaging is essential for planning revascularization. Duplex ultrasound provides detailed information about the location and severity of arterial blockages. For complex cases, CT angiography or invasive angiography maps the entire arterial tree from the groin to the foot, allowing the surgeon to plan the optimal revascularization approach.
Why Is Urgent Revascularization the Only Path to Limb Salvage?
CLTI is not a condition that improves with waiting. Without restoring blood flow, the natural history is relentlessly progressive: rest pain worsens, wounds enlarge, infection sets in, gangrene spreads, and ultimately, amputation becomes inevitable.
The principle is simple but critically important: restore blood flow first, then treat the wound. Debriding an ischemic wound or applying expensive skin grafts is futile if the artery feeding the foot remains blocked. Revascularization is the foundation upon which all other treatments (wound care, antibiotics, offloading) are built.
In patients with CLTI who are candidates for revascularization, the goal is to perform the procedure within days to a few weeks of diagnosis. Delays of even a few weeks can allow infection to spread from soft tissue to bone, converting a salvageable foot into one that requires major amputation.
The urgency is driven by infection. Once a wound becomes infected in the setting of severe ischemia, the combination is explosive. Poor blood flow means antibiotics cannot reach the infected tissue in adequate concentrations. The immune system cannot mount an effective response. Bacteria multiply unchecked, destroying soft tissue and bone. This is why the Global Vascular Guidelines recommend performing urgent surgical drainage and debridement (including minor amputation if needed) and commencing antibiotic treatment in all patients with suspected CLTI who present with deep space foot infection or wet gangrene.
What Are the Treatment Pathways for CLTI?
Revascularization for CLTI falls into two main categories: endovascular (minimally invasive) and open surgical bypass. The choice between them depends on multiple factors, including the anatomy of the blockage, the availability of suitable vein for bypass, and the patient’s overall health and life expectancy.
Evidence from the BEST-CLI Trial
The landmark BEST-CLI trial, which enrolled 1,830 patients with CLTI, provided high-quality evidence to guide this decision. In patients with adequate saphenous vein for bypass, surgical bypass using the patient’s own vein was associated with a lower rate of major reinterventions (9.2% vs. 23.3%) and a lower rate of above-ankle amputation (10.3% vs. 14.8%) compared to endovascular therapy. However, there was no difference in mortality between the two approaches. In patients without suitable vein for bypass, outcomes were similar between surgical bypass using alternative conduits (such as prosthetic grafts) and endovascular therapy.
Endovascular First Approach
For many patients, endovascular therapy has become the first-line treatment, particularly for those with high surgical risk or limited life expectancy. Endovascular techniques have a high technical success rate and favorable limb salvage rate. They are less invasive, often performed through a small puncture in the groin, with shorter hospital stays and faster recovery.
Open Surgical Bypass
Open surgical bypass remains the preferred approach for patients with long, diffuse, heavily calcified blockages, particularly when a single-segment great saphenous vein is available. Preparing for vascular surgery involves preoperative testing, medication management, and sometimes preoperative antibiotic prophylaxis.
In some cases, a hybrid approach combining endovascular and open techniques is most appropriate. For example, an iliac artery stent may be placed to improve inflow, followed by a femoral-to-pedal bypass to restore direct flow to the foot.
New Technologies for No-Option CLTI
New technologies continue to expand the options for patients with CLTI. For patients with no-option CLTI (those with no suitable target for bypass or endovascular intervention), transcatheter arterialization of the deep veins (TADV) has emerged as a promising salvage technique. Early real-world studies show that TADV achieves high rates of amputation-free survival and limb salvage in patients at high risk for major amputation.
What Is the Role of Antibiotics in CLTI Patients?
Antibiotics play a supporting but essential role in CLTI management. They do not open blocked arteries, and they do not heal ischemic tissue. However, once infection is present, appropriate antibiotic therapy is critical.
The Global Vascular Guidelines recommend antibiotic therapy for patients with deep space foot infection or wet gangrene. A 2023 study provided new evidence supporting the use of perioperative therapeutic antibiotics in CLTI patients undergoing surgical revascularization who have a foot infection (fI) score of 1 or higher. In this study, perioperative therapeutic antibiotics reduced the incidence of postoperative limb-associated infection from 44.8% to 0% in patients with an fI score ≥1. For patients without infection (fI score 0), therapeutic antibiotics provided no benefit.
Antibiotics in vascular surgery are most effective when combined with surgical debridement of infected and necrotic tissue. For patients with osteomyelitis (bone infection), antibiotic courses typically last 4 to 6 weeks and may require initial intravenous therapy.
Patients and families often ask whether antibiotics alone can heal a diabetic foot wound or an ischemic ulcer. The answer is clear: no. Timely antibiotic therapy reduces amputation rates by controlling infection, but it is never a substitute for revascularization. The sequence is always the same: restore blood flow, debride infected tissue, and use antibiotics as an adjunct, not as primary therapy.
When Is Amputation Necessary, and What Does Limb Salvage Involve?
Despite best efforts, not all limbs can be saved. Amputation may be necessary when:
- Extensive gangrene has destroyed so much of the foot that revascularization cannot salvage functional tissue.
- The patient is not a candidate for revascularization due to severe comorbidities or lack of suitable target vessels.
- Sepsis from an infected, non-viable limb threatens the patient’s life.
In these situations, amputation is not a failure; it is a life-saving procedure. The goal is to perform the lowest possible level of amputation that removes all non-viable tissue, typically a below-knee amputation rather than an above-knee amputation whenever possible, because preserving the knee joint significantly improves rehabilitation potential and quality of life.
However, major amputation carries its own substantial risks. One-year mortality after major amputation is 19.2%, rising to 48.7% at three years and 61.3% at five years. This highlights why limb salvage, when possible, is almost always the preferred path.
The Importance of a Multidisciplinary Limb Salvage Team
For the vast majority of patients with CLTI, limb salvage is achievable. Multidisciplinary limb salvage programs that bring together vascular surgeons, podiatrists, infectious disease specialists, and wound care experts have been shown to improve outcomes. In the BEST-CLI trial, patients treated at centers with a formally defined CLTI team had a 40% lower risk of major amputation on multivariable analysis compared to centers without such a team. Teams included revascularization specialists (vascular surgery, interventional cardiology, interventional radiology) in 92% of centers, podiatry in 32%, and wound care in 22%.
At Silicon Valley Surgical Associates (SVSA), our limb salvage program brings together board-certified vascular surgeons and general surgeons in a coordinated, multidisciplinary approach. We offer same-week diagnostic testing, in-office endovascular procedures, and seamless coordination with infectious disease colleagues and wound care specialists. Our surgeons work together to evaluate your limb threat, restore blood flow, control infection, and heal your wound. We perform both endovascular and open surgical revascularization on site, and we are committed to exploring every option before considering amputation.
Frequently Asked Questions About Critical Limb-Threatening Ischemia
Can CLTI be reversed without surgery?
No. CLTI requires revascularization (either endovascular angioplasty/stent or open surgical bypass) to restore adequate blood flow. Medications alone cannot reverse severe ischemia.
How quickly do I need treatment for CLTI?
Ideally within days to a few weeks of diagnosis. Delays allow infection to spread and tissue to die, reducing the chance of limb salvage. If you have rest pain, a non-healing wound, or gangrene, you should see a vascular surgeon immediately.
Is amputation always the outcome if I have CLTI?
No. With timely revascularization, limb salvage rates exceed 85% in experienced multidisciplinary programs. Amputation is reserved for limbs with extensive, non-salvageable tissue loss or when revascularization is not anatomically possible.
What is the difference between CLTI and PAD?
PAD (peripheral artery disease) is a broader term that includes all stages of arterial narrowing. CLTI is the most severe stage of PAD, characterized by rest pain, non-healing wounds, or gangrene. Not everyone with PAD develops CLTI, but CLTI always indicates severe, limb-threatening PAD.
Medical Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult your physician or a vascular surgeon for any health concerns or before starting any treatment.
Author and Review Information
Author: Charles D. Goff, MD, FACS
Medical Reviewer: Jacek J. Paszkowiak, MD, FACS
Last reviewed: March 15, 2026